Concerning Rise in Age-Related Health Issues Among Young Adults

Younger Americans under 55 are seeing more severe heart attacks and higher early death rates. Find out why this is happening and what it means for their health.

#YoungAdultHealth, #HeartAttackRisk, #EarlyDeaths, #USHealth, #PublicHealth

https://newsletter.tf/young-adults-us-heart-attacks-early-deaths/

Young adults in US face more heart attacks and early deaths

Younger Americans under 55 are seeing more severe heart attacks and higher early death rates. Find out why this is happening and what it means for their health.

More young adults under 55 are having severe heart attacks. This is a worrying change compared to previous years, where such issues were less common in this age group.

#YoungAdultHealth, #HeartAttackRisk, #EarlyDeaths, #USHealth, #PublicHealth

https://newsletter.tf/young-adults-us-heart-attacks-early-deaths/

Young adults in US face more heart attacks and early deaths

Younger Americans under 55 are seeing more severe heart attacks and higher early death rates. Find out why this is happening and what it means for their health.

Concerning Rise in Age-Related Health Issues Among Young Adults

Younger Americans under 55 are seeing more severe heart attacks and higher early death rates. Find out why this is happening and what it means for their health.

#YoungAdultHealth, #HeartAttackRisk, #EarlyDeaths, #USHealth, #PublicHealth

https://newsletter.tf/young-adults-us-heart-attacks-early-deaths/

More young adults under 55 are having severe heart attacks. This is a worrying change compared to previous years, where such issues were less common in this age group.

#YoungAdultHealth, #HeartAttackRisk, #EarlyDeaths, #USHealth, #PublicHealth

https://newsletter.tf/young-adults-us-heart-attacks-early-deaths/

Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.
#YonhapInfomax #Amgen #Repatha #HeartAttackRisk #LDLCholesterol #ClinicalTrialResults #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90246
Amgen CEO Says Cholesterol Drug Proven to Cut Heart Attack Risk by 36%

Amgen CEO Bob Bradway announced that new clinical trial data show Repatha significantly reduces heart attack risk by 36% when combined with standard therapies, underscoring the importance of lowering LDL cholesterol for high-risk patients.

Yonhap Infomax